Paul-Ehrlich-Institut

Hinweis zur Verwendung von Cookies

Zur Bereitstellung und Optimierung unseres Webauftritts möchten wir gerne statistische Informationen vollständig anonymisiert erfassen und analysieren. Dürfen wir hierzu vorübergehend einen Statistik-Cookie setzen?

Sie können Ihre Einwilligung jederzeit in unserer Datenschutzerklärung widerrufen.

OK

Publikationen aus 2009

Autorinnen und Autoren des Paul-Ehrlich-Instituts sind durch Fettdruck kenntlich gemacht. Wenn Online-Abstracts oder Volltexte zu den Publikationen verfügbar sind, so sind diese verlinkt.

Albrecht M, Kühne Y, Ballmer-Weber BK, Becker WM, Holzhauser T, Lauer I, Reuter A, Randow S, Falk S, Wangorsch A, Lidholm J, Reese G, Vieths S (2009): Relevance of IgE binding to short peptides for the allergenic activity of food allergens.
J Allergy Clin Immunol 124: 328-336.
Online-Abstract

Almqvist C, Bradding PB, Chakir J, Ebo D, Grattan C, Kariyawasam HH, Savilahti E, Scadding GK, Vieths S, Wardlaw AJ, Woodfolk J (2009): Developments in the field of allergy in 2008 through the eyes of Clinical & Experimental Allergy.
Clin Exp Allergy 39: 1482-1498.
Online-Abstract

Anz D, Thaler R, Stephan N, Waibler Z, Trauscheid MJ, Scholz C, Kalinke U, Barchet W, Endres S, Bourquin C (2009): Activation of melanoma differentiation-associated gene 5 causes rapid involution of the thymus.
J Immunol 182: 6044-6050.
Online-Abstract

Bauermeister K, Ballmer-Weber BK, Bublin M, Fritsche P, Hanschmann KM, Hoffmann-Sommergruber K, Lidholm J, Oberhuber C, Randow S, Holzhauser T, Vieths S (2009): Assessment of component-resolved in vitro diagnosis of celeriac allergy.
J Allergy Clin Immunol 124: 1273-1281.e2.
Online-Abstract

Baylis SA, Buchheit KH (2009): A proficiency testing study to evaluate laboratory performance for the detection of different genotypes of parvovirus B19.
Vox Sang 97: 13-20.
Online-Abstract

Berkner H, Neudecker P, Mittag D, Ballmer-Weber BK, Schweimer K, Vieths S, Rösch P (2009): Cross-reactivity of pollen and food allergens: soybean Gly m 4 is a member of the Bet v 1 superfamily and closely resembles yellow lupine proteins.
Biosci Rep 29: 183-192.
Online-Abstract

Buchholz CJ, Mühlebach MD, Cichutek K (2009): Lentiviral vectors with measles virus glycoproteins – dream team for gene transfer?.
Trends Biotechnol 27: 259-265.
Online-Abstract

Canonica GW, Bousquet J, Casale T, Lockey RF, Baena-Cagnani CE, Pawankar R, Potter PC, Bousquet PJ, Cox LS, Durham SR, Nelson HS, Passalacqua G, Ryan DP, Brozek JL, Compalati E, Dahl R, Delgado L, van Wijk RG, Gower RG, Ledford DK, Filho NR, Valovirta EJ, Yusuf OM, Zuberbier T, Akhanda W, Almarales RC, Ansotegui I, Bonifazi F, Ceuppens J, Chivato T, Dimova D, Dumitrascu D, Fontana L, Katelaris CH, Kaulsay R, Kuna P, Larenas-Linnemann D, Manoussakis M, Nekam K, Nunes C, O'Hehir R, Olaguibel JM, Onder NB, Park JW, Priftanji A, Puy R, Sarmiento L, Scadding G, Schmid-Grendelmeier P, Seberova E, Sepiashvili R, Solé D, Togias A, Tomino C, Toskala E, van Beever H, Vieths S (2009): Sub-lingual immunotherapy: World Allergy Organization Position Paper 2009.
Allergy 64: 1-59.

Cervantes-Barragán L, Kalinke U, Züst R, König M, Reizis B, López-Macías C, Thiel V, Ludewig B (2009): Type I IFN-mediated protection of macrophages and dendritic cells secures control of murine coronavirus infection.
J Immunol 182: 1099-1106.
Online-Abstract

Cretich M, Di Carlo G, Giudici C, Pokoj S, Lauer I, Scheurer S, Chiari M (2009): Detection of allergen specific immunoglobulins by microarrays coupled to microfluidics.
Proteomics 9: 2098-2107.
Online-Abstract

Cußler K, Hoffmann A, Nesseler A, Fröhlich T (2009): Auswertung der Nebenwirkungsmeldungen nach der Impfung gegen die Blauzungenkrankheit in Hessen für das Jahr 2008.
Praktischer Tierarzt 90: 142-150.
Online-Abstract

Damert A, Raiz J, Horn AV, Löwer J, Wang H, Xing J, Batzer MA, Löwer R, Schumann GG (2009): 5'-transducing SVA retrotransposon groups spread efficiently throughout the human genome.
Genome Res 19: 1992-2008.
Online-Abstract

Dauber B, Martinez-Sobrido L, Schneider J, Hai R, Waibler Z, Kalinke U, Garcia-Sastre A, Wolff T (2009): Influenza B virus ribonucleoprotein is a potent activator of the antiviral kinase PKR.
PLoS Pathog 5: e1000473.
Fulltext

Dedic A, Gadermaier G, Vogel L, Ebner C, Vieths S, Ferreira F, Egger M (2009): Immune recognition of novel isoforms and domains of the mugwort pollen major allergen Art v 1.
Mol Immunol 46: 416-421.
Online-Abstract

Detje CN, Meyer T, Schmidt H, Kreuz D, Rose JK, Bechmann I, Prinz M, Kalinke U (2009): Local type I IFN receptor signaling protects against virus spread within the central nervous system.
J Immunol 182: 2297-2304.
Online-Abstract

Dschietzig T, Bartsch C, Wessler S, Baumann G, Stangl K (2009): Autoregulation of human relaxin-2 gene expression critically involves relaxin and glucocorticoid receptor binding to glucocorticoid response half-sites in the relaxin-2 promoter.
Regul Pept 155: 163-173.
Online-Abstract

Epstein J, Seitz R, Dhingra N, Ganz PR, Gharehbaghian A, Spindel R, Teo D, Reddy R (2009): Role of regulatory agencies.
Biologicals 37: 94-102.
Online-Abstract

Essers MA, Offner S, Blanco-Bose WE, Waibler Z, Kalinke U, Duchosal MA, Trumpp A (2009): IFNalpha activates dormant haematopoietic stem cells in vivo.
Nature 458: 904-908.
Online-Abstract

Etscheid M, Muhl L, Pons D, Preissner KT, Ruf W, Jukema W, Kanse SM (2009): The Marburg I polymorphism (G534E) of factor VII activating protease (FSAP) prevents fvii activation, but contributes to thromboembolic risk due to FVIII activation.
J Thromb Haemost 7: Abstract OC-TH-110.

Funke S, Schneider IC, Glaser S, Mühlebach MD, Moritz T, Cattaneo R, Cichutek K, Buchholz CJ (2009): Pseudotyping lentiviral vectors with the wildtype measles virus glycoproteins improves titer and selectivity.
Gene Ther 16: 700-705.
Online-Abstract

Gadermaier G, Harrer A, Girbl T, Palazzo P, Himly M, Vogel L, Briza P, Mari A, Ferreira F (2009): Isoform identification and characterization of Art v 3, the lipid-transfer protein of mugwort pollen.
Mol Immunol 46: 1919-1924.
Online-Abstract

Gadermaier G, Jahn-Schmid B, Vogel L, Egger M, Himly M, Briza P, Ebner C, Vieths S, Bohle B, Ferreira F (2009): Targeting the cysteine-stabilized fold of Art v 1 for immunotherapy of Artemisia pollen allergy.
Mol Immunol 47: 1292-1298.
Online-Abstract

Gebhardt C, Vieths S, Gubesch M, Averbeck M, Simon JC, Treudler R (2009): 10 kDa lipid transfer protein: the main allergenic structure in a German patient with anaphylaxis to blueberry.
Allergy 64: 498-499.

Gravemann U, Kusch M, Koenig H, Mohr H, Mueller TH (2009): Thrombin generation capacity of methylene blue-treated plasma prepared by the theraflex MB plasma system.
Transfus Med Hemother 36: 122-127.
Online-Abstract

Halbauer J, Siekmeier R, Funk M (2009): Die Sicherheit von Hochrisiko-in-vitro-Diagnostika : Internationale und nationale Maßnahmen.
Bundesgesundheitsbl - Gesundheitsforsch - Gesundheitsschutz 52: 610-618.
Online-Abstract Volltext

Hansen KS, Ballmer-Weber BK, Sastre J, Lidholm J, Andersson K, Oberhofer H, Lluch-Bernal M, Ostling J, Mattsson L, Schocker F, Vieths S, Poulsen LK (2009): Component-resolved in vitro diagnosis of hazelnut allergy in Europe.
J Allergy Clin Immunol 123: 1134-1141.
Online-Abstract

Haschberger B, Hesse J, Heiden M, Seitz R, Schramm W (2009): DHR--ready for take-off.
Hämostaseologie 29: S19-S21.
Online-Abstract

Henseler O, Baumann L, Kaier RH (2009): Pflicht zur Meldung des Verbrauches von Blutprodukten an das Paul-Ehrlich-Institut und Überwachung der Qualitätssicherung in der Hämotherapie durch die Landesärztekammer Hessen (LÄKH).
Hess Ärztebl 70: 54-55.

Henseler O, Heiden M, Haschberger B, Hesse J, Seitz R (2009): Bericht zur Meldung nach § 21 TFG für das Jahr 2007.
Bundesgesundheitsbl - Gesundheitsforsch - Gesundheitsschutz 52: 715-731.
Online-Abstract Text

Hilger A, Kerr J (2009): EU regulatory perspective on rare diseases: Focus on plasma protein related disorders.
Pharmaceuticals Policy and Law 11: 387-395.

Himly M, Nony E, Chabre H, Van Overtwelt L, Neubauer A, van Ree R, Buchheit KH, Vieths S, Moingeon P, Ferreira F (2009): Standardization of allergen products: 1. Detailed characterization of GMP-produced recombinant Bet v 1.0101 as biological reference preparation.
Allergy 64: 1038-1045.
Online-Abstract

Hoffmann A, Cußler K (2009): Impfkampagne zur Bekämpfung der Blauzungenkrankheit : Erste Analyse und Bewertung der 2008 gemeldeten Impfreaktionen.
Dtsch Tierärztebl 2/2009: 166-168.
Volltext

Holzhauser T: Analytische Methoden und Grenzen der Allergenquantifizierung.
In: Richter K, Kramarz S, Niemann B, Grossklaus R, Lampen A (Hrsg.), Schwellenwerte zur Allergenkennzeichnung von Lebensmitteln – Expertengespräch im Rahmen der BMELV-Konferenz 2008 "Allergien: Bessere Information, höhere Lebensqualität" am 15. Oktober 2008 in Berlin. Berlin: Bundesinstitut für Risikobewertung, 2009. S. 27-36

Holzhauser T, Wackermann O, Ballmer-Weber BK, Bindslev-Jensen C, Scibilia J, Perono-Garoffo L, Utsumi S, Poulsen LK, Vieths S (2009): Soybean (Glycine max) allergy in Europe: Gly m 5 (beta-conglycinin) and Gly m 6 (glycinin) are potential diagnostic markers for severe allergic reactions to soy.
J Allergy Clin Immunol 123: 452-458.
Online-Abstract

Husmann M, Beckmann E, Boller K, Kloft N, Tenzer S, Bobkiewicz W, Neukirch C, Bayley H, Bhakdi S (2009): Elimination of a bacterial pore-forming toxin by sequential endocytosis and exocytosis.
FEBS Lett 583: 337-344.
Online-Abstract

Ilchmann A, Burgdorf S, Scheurer S, Waibler Z, Nagai R, Wellner A, Yamamoto Y, Yamamoto H, Henle T, Kurts C, Kalinke U, Vieths S, Toda M (2009): Glycation of a food allergen by the Maillard reaction enhances its T-cell immunogenicity: role of macrophage scavenger receptor class A type I and II.
J Allergy Clin Immunol 125: 175-83.
Online-Abstract

Jahn EM, Schneider CK (2009): How to systematically evaluate immunogenicity of therapeutic proteins – regulatory considerations.
N Biotechnol 25: 280-286.
Online-Abstract

Jappe U, Vieths S (2009): Lupine, a source of new as well as hidden food allergens.
Mol Nutr Food Res 54: 113-126.
Online-Abstract

Kamp C (2009): Understanding the HIV coreceptor switch from a dynamical perspective.
BMC Evol Biol 9: 274.
Volltext

Keller-Stanislawski B, Lohmann A, Günay S, Heiden M, Funk MB (2009): The German Haemovigilance System–reports of serious adverse transfusion reactions between 1997 and 2007.
Transfus Med 19: 340-349.
Online-Abstract

Krämer B, Schildger H, Behrensdorf-Nicol HA, Hanschmann KM, Duchow K (2009): The rapid fluorescent focus inhibition test is a suitable method for batch potency testing of inactivated rabies vaccines.
Biologicals 37: 119-26.
Online-Abstract

Krause S, Reese G, Randow S, Zennaro D, Quaratino D, Palazzo P, Ciardiello MA, Petersen A, Becker WM, Mari A (2009): Lipid transfer protein (Ara h 9) as a new peanut allergen relevant for a Mediterranean allergic population.
J Allergy Clin Immunol 124: 771-778.
Online-Abstract

Kreijtz JH, Suezer Y, de Mutsert G, van den Brand JM, van Amerongen G, Schnierle BS, Kuiken T, Fouchier RA, Löwer J, Osterhaus AD, Sutter G, Rimmelzwaan GF (2009): Recombinant modified vaccinia virus Ankara expressing the hemagglutinin gene confers protection against homologous and heterologous H5N1 influenza virus infections in macaques.
J Infect Dis 199: 405-413.
Online-Abstract

Lauer I, Dueringer N, Pokoj S, Rehm S, Zoccatelli G, Reese G, Miguel-Moncin MS, Cistero-Bahima A, Enrique E, Lidholm J, Vieths S, Scheurer S (2009): The non-specific lipid transfer protein, Ara h 9, is an important allergen in peanut.
Clin Exp Allergy 39: 1427-1437.
Online-Abstract

Lehmann MH, Kastenmüller W, Kademir JD, Brandt F, Suezer Y, Sutter G (2009): Modified vaccinia virus Ankara (MVA) triggers chemotaxis of monocytes and early respiratory immigration of leukocytes by induction of CCL2 expression.
J Virol 83: 2540-2552.
Online-Abstract

Loessner H, Leschner S, Endmann A, Westphal K, Wolf K, Kochruebe K, Miloud T, Altenbuchner J, Weiss S (2009): Drug-inducible remote control of gene expression by probiotic Escherichia coli Nissle 1917 in intestine, tumor and gall bladder of mice.
Microbes Infect 11: 1097-1115.
Online-Abstract

Lorenz AR, Lüttkopf D, May S, Scheurer S, Vieths S (2009): The Principle of Homologous Groups in Regulatory Affairs of Allergen Products - A Proposal.
Int Arch Allergy Immunol 148: 1-17.
Online-Abstract

May S, Kaul S, Lüttkopf D, Vieths S (2009): Regulation, role and future of named patient products in Germany.
Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M 96: 193-197; discussion 197-199.

Motitschke A, Jungbäck C (2009): Test for extraneous agents in avian inactivated vaccines using PCR: Detection of infectious bronchitis virus.
Proceedings of the VI. International Symposium on Avian Corona- and Pneumoviruses and Complicating Pathogens, Rauischholzhausen, Germany, 14-17 June 2009: 118-124.

Neske F, Schörner C, Buchheit KH, Costanzo A, Hanschmann KM, Himly M, Holzhauser T, Ferreira F, Kaul S, Vieths S, van Ree R (2009): BSP090--the follow-up to CREATE.
Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M 96: 12-19; discussion 19-20.

Nübling CM, Heiden M, Chudy M, Kress J, Seitz R, Keller-Stanislawski B, Funk MB (2009): Experience of mandatory nucleic acid test (NAT) screening across all blood organizations in Germany: NAT yield versus breakthrough transmissions.
Transfusion 49: 1850-1858.
Online-Abstract

Padavattan S, Flicker S, Schirmer T, Madritsch C, Randow S, Reese G, Vieths S, Lupinek C, Ebner C, Valenta R, Markovic-Housley Z (2009): High-affinity IgE recognition of a conformational epitope of the major respiratory allergen Phl p 2 as revealed by X-ray crystallography.
J Immunol 182: 2141-2151.
Online-Abstract

Paran N, Suezer Y, Lustig S, Israely T, Schwantes A, Melamed S, Katz L, Preuß T, Hanschmann KM, Kalinke U, Erez N, Levin R, Velan B, Löwer J, Shafferman A, Sutter G (2009): Postexposure immunization with modified vaccinia virus Ankara or conventional lister vaccine provides solid protection in a murine model of human smallpox.
J Infect Dis 199: 39-48.
Online-Abstract

Perkovic M, Schmidt S, Marino D, Russell RA, Stauch B, Hofmann H, Kopietz F, Kloke BP, Zielonka J, Ströver H, Hermle J, Lindemann D, Pathak VK, Schneider G, Löchelt M, Cichutek K, Münk C (2009): Species-specific inhibition of APOBEC3C by the prototype foamy virus protein bet.
J Biol Chem 284: 5819-5826.
Online-Abstract

Pfleiderer M (2009): Stability of vaccines - bridging from stability data to continuous safety and efficacy throughout shelf life - an always reliable approach?.
Biologicals 37: 364-368.
Online-Abstract

Pfleiderer M: Kapitel 7.1 - Prävention/Impfen.
Zepp F ; Ruf BR (Hrsg.), H1N1-Update 2009 : Kompendium Influenza 2009. Wiesbaden: med update, 2009 ISBN 978-3-642-10312-4

Pfleiderer M: Zusatzkapitel - Neue Influenza A/H1N1 und die "Schweinegrippe"-Pandemie 2009 (Kapitel 13.4).
In: Haas W (Hrsg.), Influenza: Prävention, Diagnostik, Therapie und öffentliche Gesundheit - mit Zugang zum Elsevier-Portal 1. Aufl. München: Urban & Fischer Verlag/Elsevier GmbH, 2009. 27-35

Pfleiderer M: Influenzaimpfstoffe (Kapitel 6).
In: Haas W (Hrsg.), Influenza: Prävention, Diagnostik, Therapie und öffentliche Gesundheit - mit Zugang zum Elsevier-Portal 1. Aufl. München: Urban & Fischer Verlag/Elsevier GmbH, 2009. 112-136

Reese I, Zuberbier T, Bunselmeyer B, Erdmann S, Henzgen M, Fuchs T, Jäger L, Kleine-Tebbe J, Lepp U, Niggemann B, Raithel M, Saloga J, Vieths S, Werfel T (2009): Diagnostic approach for suspected pseudoallergic reaction to food ingredients.
J Dtsch Dermatol Ges 7: 70-77.
Online-Abstract

Reinhardt J, Kretzschmar E, Cichutek K: Paul-Ehrlich-Institut : a federal research and regulatory institute with international competence for vaccines and biomedicines.
Hessen – Gateway to Contract Research in Europe: A practical Guide to Sites and Services, second edition. Wiesbaden: HA Hessen Agentur, 2009. 11-13
(Aktionslinie Hessen-Biotech 8)

Reuter A, Lüttkopf D, Vieths S (2009): New frontiers in allergen standardization.
Clin Exp Allergy 39: 307-309.

Röder M, Vieths S, Holzhauser T (2009): Commercial lateral flow devices for rapid detection of peanut (Arachis hypogaea) and hazelnut (Corylus avellana) cross-contamination in the industrial production of cookies.
Anal Bioanal Chem 395: 103-109.
Online-Abstract

Salge-Bartels U, Huber HM, Kleiner K, Volkers P, Seitz R, Heiden M (2009): Evaluation of Quality Parameters for Cord Blood Donations.
Transfus Med Hemother 36: 317-324.

Scheurer S, Sonnewald S (2009): Genetic engineering of plant food with reduced allergenicity.
Front Biosci 14: 59-71.
Online-Abstract

Schmidt M, Korn K, Nübling CM, Chudy M, Kress J, Horst HA, Geusendam G, Hennig H, Sireis W, Rabenau H, Doerr HW, Berger A, Hourfar MK, Gubbe K, Karl A, Fickenscher H, Tischer K, Babiel R, Seifried E, Gürtler L (2009): First transmission of human immunodeficiency virus Type 1 by a cellular blood product after mandatory nucleic acid screening in Germany.
Transfusion 49: 1836-1844.
Online-Abstract

Schneider CK, Papaluca M, Kurki P (2009): A European perspective on immunogenicity evaluation.
Nat Biotechnol 27: 507-508.
Online-Abstract

Schulten V, Radakovics A, Hartz C, Mari A, Vazquez-Cortes S, Fernandez-Rivas M, Lauer I, Jahn-Schmid B, Eiwegger T, Scheurer S, Bohle B (2009): Characterization of the allergic T-cell response to Pru p 3, the nonspecific lipid transfer protein in peach.
J Allergy Clin Immunol 124: 100-107.
Online-Abstract

Seitz R, Beekes M, Blümel J, Burger R, von Dewitz C, Gröner A, Heiden M, Kretzschmar H, Nübling M, Schlenkrich U, Schottstedt V, Strobel J, Willkommen H, Wirsing von König CH, Zerr I (2009): Report of the Working Group 'Overall Blood Supply Strategy with Regard to Variant Creutzfeldt-Jakob Disease (vCJD)'.
Transfus Med Hemother 36: 79-93.

Seitz R, Gürtler L, Blümel J, Burger R, Drosten C, Gröner A, Heiden M, Hildebrandt M, Jansen B, Montag-Lessing T, Offergeld R, Pauli G, Schlenkrich U, Schottstedt V, Strobel J, Willkommen H, Wirsing von König CH (2009): Arboprotozoen.
Bundesgesundheitsbl - Gesundheitsforsch - Gesundheitsschutz 52: 123-146.
Volltext

Seitz R, Gürtler L, Blümel J, Burger R, Drosten C, Gröner A, Heiden M, Hildebrandt M, Jansen B, Montag-Lessing T, Offergeld R, Pauli G, Schlenkrich U, Schottstedt V, Strobel J, Willkommen H, Wirsing von König CH (2009): Arboprotozoae.
Transfus Med Hemother 36: 8-31.

Seitz R, Heiden M, Offergeld R, Burger R (2009): Still in Focus: Assessment of Blood-Borne Pathogens.
Transfus Med Hemother 36: 5-6.

Siekmeier R, Halbauer J, Mientus W, Wetzel D (2009): Safety of laboratory analyzers for infection testing - results of the market surveillance by the BfArM until End 2007.
Eur J Med Res 14: 216-226.
Online-Abstract

Sperling KM, Schwantes A, Staib C, Schnierle BS, Sutter G (2009): The orthopoxvirus 68-kilodalton ankyrin-like protein is essential for DNA replication and complete gene expression of modified vaccinia virus Ankara in nonpermissive human and murine cells.
J Virol 83: 6029-6038.
Online-Abstract

Stockinger S, Kastner R, Kernbauer E, Pilz A, Westermayer S, Reutterer B, Soulat D, Stengl G, Vogl C, Frenz T, Waibler Z, Taniguchi T, Rülicke T, Kalinke U, Müller M, Decker T (2009): Characterization of the interferon-producing cell in mice infected with Listeria monocytogenes.
PLoS Pathog 5: e1000355.
Volltext

Tapp HJ, Grundmann C, Kusch M, König H (2009): Calibrating thrombin generation in different samples: less effort with a less efficient substrate.
Open Atheroscler Thromb J 2: 6-11.

Thomas K, Maclntosh S, Bannon G, Herouet-Guicheney C, Holsapple M, Ladics G, McClain S, Vieths S, Woolhiser M, Privalle L (2009): Scientific advancement of novel protein allergenicity evaluation: an overview of work from the HESI Protein Allergenicity Technical Committee (2000-2008).
Food Chem Toxicol 47: 1041-1050.
Online-Abstract

Waibler Z, Anzaghe M, Frenz T, Schwantes A, Pöhlmann C, Ludwig H, Palomo-Otero M, Alcami A, Sutter G, Kalinke U (2009): Vaccinia virus-mediated inhibition of type I interferon responses is a multi-factorial process involving the soluble type I interferon receptor B18 and intracellular components.
J Virol 83: 1563-1571.
Online-Abstract

Wallner M, Erler A, Hauser M, Klinglmayr E, Gadermaier G, Vogel L, Mari A, Bohle B, Briza P, Ferreira F (2009): Immunologic characterization of isoforms of Car b 1 and Que a 1, the major hornbeam and oak pollen allergens.
Allergy 64: 452-460.
Online-Abstract

Weißer K, Barth I, Keller-Stanislawski B (2009): Sicherheit von Impfstoffen.
Bundesgesundheitsbl - Gesundheitsforsch - Gesundheitsschutz 52: 1053-1064.
Online-Abstract Text

Werfel T, Erdmann S, Fuchs T, Henzgen M, Kleine-Tebbe J, Lepp U, Niggemann B, Raithel M, Reese I, Saloga J, Vieths S, Zuberbier T (2009): Approach to suspected food allergy in atopic dermatitis. Guideline of the Task Force on Food Allergy of the German Society of Allergology and Clinical Immunology (DGAKI) and the Medical Association of German Allergologists (ADA) and the German Society of Pediatric Allergology (GPA).
J Dtsch Dermatol Ges 7: 265-271.
Online-Abstract

Wopfner N, Jahn-Schmid B, Schmidt G, Christ T, Hubinger G, Briza P, Radauer C, Bohle B, Vogel L, Ebner C, Asero R, Ferreira F, Schwarzenbacher R (2009): The alpha and beta subchain of Amb a 1, the major ragweed-pollen allergen show divergent reactivity at the IgE and T-cell level.
Mol Immunol 46: 2090-2097.
Online-Abstract